CGA suppresses CCl4-induced liver fibrosis by suppressing miR-21/TGF-β1/Smad7 signaling or inhibiting TLR4/NF-κB signaling and stimulating the Nrf2 pathway [22,177,178]. This evidence concerns the gene SMAD7 and Hepatic fibrosis.